Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

about

Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

Item

http://www.wikidata.org/entity/Q36316869

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

@ast

Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

@en

type

Item

label

Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

@ast

Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

@en

prefLabel

Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

@ast

Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

@en

P1476

Mucosal healing effect of nilotinib in indomethacin-induced enterocolitis: A rat model.

@en

P2093

Elif Borekci

http://www.w3.org/2001/XMLSchema#string

Gozde Dervis Hakim

http://www.w3.org/2001/XMLSchema#string

Mehtat Unlu

http://www.w3.org/2001/XMLSchema#string

Meral Karaman

http://www.w3.org/2001/XMLSchema#string

Osman Yilmaz

http://www.w3.org/2001/XMLSchema#string

Ozgul Sagol

http://www.w3.org/2001/XMLSchema#string

Pinar Ataca

http://www.w3.org/2001/XMLSchema#string

P2860

Natalizumab Induction and Maintenance Therapy for Crohn's Disease

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL

Cell signaling by receptor tyrosine kinases

The protein tyrosine kinase family of the human genome

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Extended kinase profile and properties of the protein kinase inhibitor nilotinib

Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

Inflammatory bowel disease: cause and immunobiology.

P304

12576-12585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I44.12576

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Müjde Soytürk

P577

2015-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26640333

http://www.w3.org/2001/XMLSchema#string

P932

4658611

http://www.w3.org/2001/XMLSchema#string